ArticleClinical kidney journal2025
High level of infection-related hospitalizations in the 2019-2020 French national dialysis cohort.
Article in Clinical kidney journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Dialysis patients experience a high rate of hospitalizations for infection. This work aimed to study the frequency of hospitalizations for infections and the associated risk factors in a nationwide dialysis cohort during 2019-2020. Methods: This was an observational, retrospective study using two national databases. We included 59 585 patients undergoing dialysis from 1 January 2019 to 31 December 2020. Hospitalization rates (per 1000 patient-years) were calculated from all hospital discharges with a principal or related diagnosis of infection. Infections were classified into 14 categories. The association between individual risk factors and incidence of infection-related hospitalizations was estimated with multilevel Poisson models with patients as random effects. Results: The incidence rate was 245 (95% confidence intervals (CI) 242-249) hospitalizations per 1000 patient-years, 241 (236-246) and 249 (244-254) in 2019 and 2020. After excluding COVID-19-related hospitalizations, the 2020 incidence was 197 (192-201). The main source of infection-related hospitalizations was pulmonary [93 (91-96)] followed by sepsis [33 (32-34)], digestive excluding peritonitis [25 (24-26)], cutaneous [24 (23-26)], urinary [18 (17-19)], and osteoarticular [9 (8-9)]. Except for pulmonary infection lower in 2020, attributed to barrier measures and lockdowns, there were no major discrepancies in incidence between 2019 and 2020. The main factors associated with risk of infection were male gender; low albumin level; presence of diabetes, chronic respiratory failure, heart failure, and lower-limb arteritis; cirrhosis stage; walking disability; and presence of active cancer. The risk of infection-related hospitalization was increased for patients with tunneled catheters and arteriovenous grafts and those under peritoneal dialysis compared with patients with arteriovenous fistula [1.63 (95% CI 1.52-1.76), 1.30 (1.11-1.53) and 1.73 (1.53-1.96); all Conclusion: The risk of hospitalization for infection is high in dialysis patients, which calls for intensified prevention measures. Lockdown and shielding barriers were efficient to decrease the incidence of pulmonary infections but not other infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.